TMCI - Treace Medical Concepts - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TMCI is currently covered by 6 analysts with an average price target of $8.36. This is a potential upside of $2.59 (44.89%) from yesterday's end of day stock price of $5.77.

Treace Medical Concepts's activity chart (see below) currently has 34 price targets and 51 ratings on display. The stock rating distribution of TMCI is 53.33% BUY and 46.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.92% with an average time for these price targets to be met of 66.67 days.

Highest price target for TMCI is $8, Lowest price target is $7, average price target is $7.75.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 11-Apr-2025. First documented stock forecast 18-May-2021.

Best performing analysts who are covering TMCI - Treace Medical Concepts:

Andrew Ranieri Rick Wise Richard Newitter Danielle Antalffy Robbie Marcus Ryan Zimmerman

Currently out of the existing stock ratings of TMCI, 16 are a BUY (53.33%), 14 are a HOLD (46.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$8

$2.26 (39.37%)

$9.5

1 months 25 days ago
(11-Apr-2025)

6/14 (42.86%)

$1.26 (18.69%)

73

Hold

$8

$2.26 (39.37%)

$6

6 months 30 days ago
(06-Nov-2024)

6/11 (54.55%)

$0.22 (2.83%)

54

Hold

$7

$1.26 (21.95%)

$6.5

9 months 29 days ago
(07-Aug-2024)

2/5 (40%)

$0.5 (7.69%)

67

Hold

$8

$2.26 (39.37%)

$31

1 years 28 days ago
(08-May-2024)

1/4 (25%)

$3.83 (91.85%)

64

Hold

$18

1 years 28 days ago
(08-May-2024)

1/5 (20%)

$4.48 (33.14%)

120

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TMCI (Treace Medical Concepts) average time for price targets to be met?

On average it took 66.67 days on average for the stock forecasts to be realized with a an average price target met ratio 39.92

Which analyst has the current highest performing score on TMCI (Treace Medical Concepts) with a proven track record?

DREW RANIERI

Which analyst has the current lower performing score on TMCI (Treace Medical Concepts) with a proven track record?

RYAN ZIMMERMAN

Which analyst has the most public recommendations on TMCI (Treace Medical Concepts)?

Drew Ranieri works at MORGAN STANLEY and has 4585 price targets and 2484 ratings on TMCI

Which analyst is the currently most bullish on TMCI (Treace Medical Concepts)?

Drew Ranieri with highest potential upside - $5.79

Which analyst is the currently most reserved on TMCI (Treace Medical Concepts)?

Ryan Zimmerman with lowest potential downside - -$0

Treace Medical Concepts in the News

Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, has filed a securities class action lawsuit in the United States District Court for the Middle District of Florida against Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI), and certain...

Shareholders that lost money on Treace Medical Concepts, Inc.(TMCI) should contact Levi & Korsinsky about pending Class Action - TMCI

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. (“Treace Medical Concepts, Inc.” or the “Company”) (NASDAQ: TMCI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Treace Medical Concepts, Inc. investors who were adversely affected by...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?